| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/11/2009 | CN101578273A Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 11/11/2009 | CN101578268A Novel compounds and methods for their production |
| 11/11/2009 | CN101578263A Sulfonamides and their use as a medicament |
| 11/11/2009 | CN101578113A Anti-KIR antibodies, formulations, and uses thereof |
| 11/11/2009 | CN101578105A Use of MAGE A3-protein D fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 11/11/2009 | CN101578098A Drug, drug induction device, magnetic detector and method of designing drug |
| 11/11/2009 | CN101575646A Application of syncytin gene in malignancy in blood system |
| 11/11/2009 | CN101575607A Recombinant BCG vaccine based on human MUC1 repetitive sequence and GM-CSF fusion expression |
| 11/11/2009 | CN101575604A Slow virus vector, preparation thereof and application thereof |
| 11/11/2009 | CN101575602A siRNA sequence for inhibiting human BFGF gene expression amplification and expression carrier and application thereof |
| 11/11/2009 | CN101575380A Tumor target and recombined human Fas ligand fusion protein and preparation method thereof |
| 11/11/2009 | CN101575379A Soluble VEGFR difunctional fusion receptors, preparation method and use thereof |
| 11/11/2009 | CN101575365A Antiviral protein and preparation method and application thereof |
| 11/11/2009 | CN101575363A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 11/11/2009 | CN101575343A Norcantharidin esterified derivatives and preparation method thereof |
| 11/11/2009 | CN101575338A Amorphous polymorph for pemetrexed disodium and preparation method thereof |
| 11/11/2009 | CN101575333A Quinazoline derivatives and medical application thereof |
| 11/11/2009 | CN101575331A Preparation method of 5'-((5-methoxyl-2-phenyl indole-1-yl) methylene)-2'-oxo-3'-tetrahydrofurfuryl |
| 11/11/2009 | CN101575315A New naphthalimide derivative, preparation method and application thereof |
| 11/11/2009 | CN101575311A Method for preparing epiphysin |
| 11/11/2009 | CN101575278A Method for preparing high purity dihydroirisquinone, pallason B |
| 11/11/2009 | CN101575277A Method for preparing high purity irisquinone, pallason A |
| 11/11/2009 | CN101574528A siRNA and expression plasmid for inhibiting human hRAD21 gene expression and pharmacy application thereof |
| 11/11/2009 | CN101574527A Liver-targeting intelligent nano-micelle prodrug system and preparation thereof |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574506A Method for preparing pingxiao preparation |
| 11/11/2009 | CN101574421A Medicament for treating leukemia and septicemia |
| 11/11/2009 | CN101574420A Application of oldenlandia diffusa acting on retinol X receptor |
| 11/11/2009 | CN101574400A Chinese medicament containing gen-seng and cordyceps |
| 11/11/2009 | CN101574398A Lupulus extractive and preparation method and application thereof |
| 11/11/2009 | CN101574393A Method for preparing salvia miltiorrhiza colloid injection or infusion |
| 11/11/2009 | CN101574386A Application of active ingredients of thunder god vine for regulating heat shock protein and retinol X receptor Alpha |
| 11/11/2009 | CN101574384A Production method for preparing anti-cancer medicament preparation and health care food by taking fibrous ginseng root as raw material |
| 11/11/2009 | CN101574381A Extractive of effective part of chloranthus glaber and preparation method thereof |
| 11/11/2009 | CN101574375A Lactobacillus health-care capsule and preparation method thereof |
| 11/11/2009 | CN101574374A Method for processing cartilage marrow of shark |
| 11/11/2009 | CN101574362A Application of N-alkanoyl cordycepin in preparing drugs for treating tumor diseases |
| 11/11/2009 | CN101574360A Application of epimedin in preparing medicines for treating diseases where estrogen needs supplementing |
| 11/11/2009 | CN101574352A Antitumor usage of 3-carbonyl-12-alkene-ursane compound |
| 11/11/2009 | CN101574340A Application of rhododendrin and salts thereof in preparing anti-tumor medicament |
| 11/11/2009 | CN101574338A Pharmaceutical composition for restraining activity of aromatizing enzyme and application thereof |
| 11/11/2009 | CN101574326A Capsule preparation containing tegafur, Jimeisita and Potassium Oxonate and preparation method thereof |
| 11/11/2009 | CN101574319A Podophyllotoxin vesicle and preparation method thereof |
| 11/11/2009 | CN101574318A Preparation method of taxol injection |
| 11/11/2009 | CN101574149A Sugared ginseng powder medicinal granules and preparation method thereof |
| 11/11/2009 | CN101574148A Ginseng powder medicinal granules |
| 11/11/2009 | CN101574144A Application of 3'-deoxyadenosine in reducing weight, enhancing insulin sensitivity and improving lipid metabolism |
| 11/11/2009 | CN100558903C Photochemical internalization for delivery of molecules into the cytosol |
| 11/11/2009 | CN100558899C Growth hormone fusion protein |
| 11/11/2009 | CN100558894C Synthetic gene encoding human epidermal growth factor 2/NEU antigen and uses thereof |
| 11/11/2009 | CN100558893C Modulation of eIF4E expression |
| 11/11/2009 | CN100558747C Immunogen by using mutant CRM197 of diphtheria toxin as carrier, preparation method, and application |
| 11/11/2009 | CN100558744C Use of a recombinant erythropoietin having high activity and reduced side effects |
| 11/11/2009 | CN100558741C 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 11/11/2009 | CN100558736C Nitryl aromatic imine substituted hexamolybdic acid tetrabutylamine derivative and preparation method and application thereof |
| 11/11/2009 | CN100558730C Garcinia acid derivatives, preparation method and application thereof in pharmacy |
| 11/11/2009 | CN100558725C Quinazoline derivatives as antiproliferative agents |
| 11/11/2009 | CN100558723C Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 11/11/2009 | CN100558715C Protein kinase inhibitors |
| 11/11/2009 | CN100558712C Therapeutic molecules and methods-1 |
| 11/11/2009 | CN100558705C N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 11/11/2009 | CN100558411C Tenascin-C nucleic acid ligands |
| 11/11/2009 | CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/11/2009 | CN100558407C Preparation of aqueous clear solution dosage forms with bile acids |
| 11/11/2009 | CN100558401C Adjuvant systems and vaccines |
| 11/11/2009 | CN100558400C Pharmaceutical composition for inducing an immune response in a human or animal |
| 11/11/2009 | CN100558395C Hybrid peptide modulate immune response |
| 11/11/2009 | CN100558369C Therapeutical treatments |
| 11/11/2009 | CN100558367C Method for enhancing the effectiveness of cancer therapies |
| 11/11/2009 | CN100558365C Conjugated anti-psychotic drugs and uses thereof |
| 11/11/2009 | CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia |
| 11/11/2009 | CN100558353C Application of chlorogenic acid in preparing medicine for treating small cell lung cancer |
| 11/11/2009 | CN100558349C Ginseng-astragalus capsule formulation and its preparing process |
| 11/11/2009 | CN100558347C Ginseng-astragalus dispersion tablet formulation, and its preparing process |
| 11/11/2009 | CN100558256C Method for preparing Chinese magnoliavine fruit functional salad jam |
| 11/10/2009 | US7615632 Nine polymorphic crystal structures based on characteristics of powder X-ray diffraction pattern exhibiting peaks at diffraction angles and infrared spectrum; antitumor and -carcinogenic agents; brain and breast cancer; refractory anaplastic astrocytoma; malignant glioma; glioblastoma multiforme |
| 11/10/2009 | US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease |
| 11/10/2009 | US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure |
| 11/10/2009 | US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 11/10/2009 | US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation |
| 11/10/2009 | US7615547 Granulates containing liposoluble substances and a process for the preparation thereof |
| 11/10/2009 | US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever |
| 11/10/2009 | US7615379 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer |
| 11/10/2009 | US7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen |
| 11/10/2009 | CA2551737C Helix 12 directed steroidal pharmaceutical products |
| 11/10/2009 | CA2491632C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 11/10/2009 | CA2481482C Tropane derivatives as ccr5 modulators |
| 11/10/2009 | CA2476257C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 11/10/2009 | CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders |
| 11/10/2009 | CA2416785C Novel arylethene-sulfonamides |
| 11/10/2009 | CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 11/10/2009 | CA2397593C Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one |
| 11/10/2009 | CA2378792C Aminothiazole derivatives and their use as crf receptor ligands |
| 11/05/2009 | WO2009135199A2 Vaccine compositions and methods |
| 11/05/2009 | WO2009135180A2 A method for generating reference controls for pharmacogenomic testing |
| 11/05/2009 | WO2009135019A2 Methods and compositions for prostate cancer immunotherapy |
| 11/05/2009 | WO2009135000A2 Inhibition of shp2/ptpn11 protein tyrosine phosphatase by nsc-117199 and analogs |
| 11/05/2009 | WO2009134962A2 Claudin-4 binding peptides, compositions and methods of use |
| 11/05/2009 | WO2009134725A2 Compositions and methods for treating progesterone-dependent conditions |
| 11/05/2009 | WO2009134723A1 Pregesteron antagonists such as cdb-4124 in the treatment of breast cancer |